We recently observed that cells in the invasive melanoma cell line, B16-BL6, highly express IDO2 whereas the less invasive melanoma cell line, B16F10, had limited expression of IDO2 in the absence of interferon-gamma (IFN-γ) induction. The gene discussed is IFNG; the disease is melanoma.